Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 May 1992:
Vol. 256. no. 5058, pp. 794 - 799
DOI: 10.1126/science.256.5058.794
Prev | Table of Contents | Next

Articles

Science, Vol 256, Issue 5058, 794-799
Copyright © 1992 by American Association for the Advancement of Science

articles

Gaucher disease: new molecular approaches to diagnosis and treatment

E Beutler

Department of Molecular, Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.

Gaucher disease is characterized by the accumulation of glucocerebroside, leading to enlargement of the liver and spleen and lesions in the bones. It is caused by an inherited deficiency of the enzyme glucocerebrosidase. Many mutations exist, but four of these account for over 97% of the mutations in Ashkenazi Jews, the population group in which Gaucher disease is the most common. Although there is a strong relation between the mutations and disease manifestations, genetic counseling is made difficult by the fact that within each genotype there is considerable variability in the severity of the disease. Intravenous infusion of glucocerebrosidase is an effective treatment, but the availability of enzyme replacement therapy is limited by its high cost. Marrow transplantation is also effective in treating the disease, but is rarely performed because of the risks involved. In the future gene transfer may become the treatment of choice.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Carrier Screening for Gaucher Disease: More Harm Than Good?.
E. Beutler (2007)
JAMA 298, 1329-1331
   Full Text »    PDF »
Effective cell and gene therapy in a murine model of Gaucher disease.
I. B. Enquist, E. Nilsson, A. Ooka, J.-E. Mansson, K. Olsson, M. Ehinger, R. O. Brady, J. Richter, and S. Karlsson (2006)
PNAS 103, 13819-13824
   Abstract »    Full Text »    PDF »
Early Use of Drastic Therapy.
K. I. Weinberg (2005)
N. Engl. J. Med. 352, 2124-2126
   Full Text »    PDF »
Study of Multimodal Evoked Potentials in Patients With Type 1 Gaucher's Disease.
A. Perretti, G. Parenti, P. Balbi, L. Titomanlio, L. Marcantonio, M. Iapoce, A. R. Frascogna, G. Andria, and L. Santoro (2005)
J Child Neurol 20, 124-128
   Abstract »    PDF »
Genetics of Iron Storage and Hemochromatosis.
E. Beutler, V. Felitti, T. Gelbart, and N. Ho (2001)
Drug Metab. Dispos. 29, 495-499
   Abstract »    Full Text »
Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population.
E. Beutler and T. Gelbart (2000)
Blood 95, 3585-3588
   Abstract »    Full Text »    PDF »
Gaucher Disease.
E. Beutler, J. Charrow, J. A. Esplin, P. Kaplan, E. H. Kolodny, G. M. Pastores, C. R. Scott, R. S. Wappner, N. J. Weinreb, and J. S. Wisch (1999)
Arch Intern Med 159, 881-882
   Full Text »    PDF »
Structure and Expression of a Dhurrinase (beta -Glucosidase) from Sorghum.
M. Cicek and A. Esen (1998)
Plant Physiology 116, 1469-1478
   Abstract »    Full Text »
Extensive Glycosphingolipid Depletion in the Liver and Lymphoid Organs of Mice Treated with N-Butyldeoxynojirimycin.
F. M. Platt, G. Reinkensmeier, R. A. Dwek, and T. D. Butters (1997)
J. Biol. Chem. 272, 19365-19372
   Abstract »    Full Text »    PDF »
Mutation analysis in 46 British and Irish patients with Gaucher's disease.
C E Hatton, A Cooper, C Whitehouse, and J E Wraith (1997)
Arch. Dis. Child. 77, 17-22
   Abstract »    Full Text »
Clinical and Biochemical Manifestations of Hyaluronidase Deficiency.
M. R. Natowicz, M. P. Short, Y. Wang, G. R. Dickersin, M. C. Gebhardt, D. I. Rosenthal, K. B. Sims, and A. E. Rosenberg (1996)
N. Engl. J. Med. 335, 1029-1033
   Full Text »    PDF »
A simplified procedure for developing multiplex PCRs..
A P Shuber, V J Grondin, and K W Klinger (1995)
Genome Res. 5, 488-493
   Abstract »    PDF »
A new diagnostic test for Gaucher disease suitable for population screening..
S A Sakallah, C Sansieri, D W Kopp, D L Cooper, and J A Barranger (1994)
Genome Res. 4, 1-5
   Abstract »    PDF »
Gene Therapy for Neurologic Disease.
S. T. Suhr and F. H. Gage (1993)
Arch Neurol 50, 1252-1268
   Abstract »    PDF »
Modern Diagnosis and Treatment of Gaucher's Disease.
E. Beutler (1993)
Arch Pediatr Adolesc Med 147, 1175-1183
   Abstract »    PDF »
Clinical Heterogeneity Among Patients With Gaucher's Disease.
E. Sidransky and E. I. Ginns (1993)
JAMA 269, 1154-1157
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)